ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Role of copper ionophore-induced death in immune microenvironment and clinical prognosis of ccRCC: An integrated analysis

Xia, Shunyao; Jia, Haixing; Qian, Zhipeng; Xiu, Youcheng*哈尔滨医科大学; 1
Frontiers in Genetics2022-10-3DOI: 10.3389/fgene.2022.994999
2被引6阅读
引用收藏
分享

摘要

Background: Clear cell renal cell carcinoma (ccRCC) is a malignancy with a high incidence rate and poor prognosis worldwide. Copper ionophore-induced death (CID) plays an important role in cancer progression. Methods: One training and three validation datasets were acquired from TCGA, GEO and ArrayExpress. K-means clustering was conducted to identify the CID subtypes. The ESTIMATE and CIBERSORT algorithms were employed to illustrate the immune microenvironment of ccRCC. LASSO Cox regression was applied to construct the CID feature-based prognostic model. The immunotherapy cohort was acquired from the literature to explore the potential risk scores for predicting immunotherapy responsiveness. Results: Two CID-related cancer subtypes of ccRCC were identified that performed different immune microenvironment characteristics and prognosis. Based on the identified subtypes, we analyzed the biological heterogeneity and constructed a gene prognostic model. The prognostic model performed well in one training dataset, three validation datasets, and different clinical pathological groups. The prognostic model has a good potential for predicting cancer immune features and immunotherapy responsiveness. Conclusion: CID plays an important role in the tumor microenvironment progression of ccRCC. The robust gene prognostic model developed can help predict cancer prognosis, immune features, and immunotherapy responsiveness.

学科与关键词

关键词
ccRCCmachine-learningbioinformaticsimmune microenvironmentprecise medicineCID
相关
加载中…
  • The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
    Zhang, Lishuo; Di, Longjiang; Liu, Jinhui; Lei, Xianli; Gu, Maoli; Zhang, Wenjing*; Wang, Yufu*Frontiers in Genetics, 2023, 14: 1039813.
  • A new thinking: deciphering the aberrance and clinical implication of copper-death signatures in clear cell renal cell carcinoma
    Jiang, Aimin; Luo, Peng; Chen, Ming; Fang, Yu; Liu, Bing; Wu, Zhenjie; Qu, Le; Wang, Anbang*; Wang, Linhui*; Cai, Chen*Cell and Bioscience, 2022, 12(1): 209.被引 5
  • Construction and validation of programmed cell death-based molecular clusters for prognostic and therapeutic significance of clear cell renal cell carcinoma
    Tang, Yanlin; Zhang, Changzheng; Ye, Chujin; Tian, Kaiwen; Zeng, Jiayi; Cheng, Shouyu; Zeng, Weinan; Yang, Bowen; Liu, Yanjun*; Yu, Yuming*Heliyon, 2023, 9(5): e15693.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Genetics
发表日期
2022-10-03
卷期
第 13 卷
页码
994999
DOI
10.3389/fgene.2022.994999
期刊等级
3区
成果收录
SCIE

作者

  • X

    Xia, Shunyao (第一作者)

    1 · harbin med univ

  • J

    Jia, Haixing

    1 · harbin med univ

查看全部 4 位作者收起作者
  • Q

    Qian, Zhipeng

    harbin med univ

  • X

    Xiu, Youcheng (通讯)

    1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417